Results 171 to 180 of about 2,698 (253)

The Burden of Urticaria in the Middle East and North Africa Region From 1990 to 2021: A Systematic Analysis Based on the GBD Study 2021

open access: yesHealth Science Reports, Volume 9, Issue 8, August 2026.
ABSTRACT Background and Aims Urticaria is a condition which can impair the quality of life of affected individuals. There is a lack of recent studies on the burden of this disease in the Middle East and North Africa (MENA) region. This article reported the incidence, prevalence, and disability‐adjusted life years (DALYs) of urticaria from 1990 to 2021 ...
Amir Sajad Bagheryan   +6 more
wiley   +1 more source

Serum Immunometabolic Biomarkers Reveal Distinct Phenotypes in Chronic Urticaria. [PDF]

open access: yesDiagnostics (Basel)
Duman N   +7 more
europepmc   +1 more source

Rupatadine Ameliorates Cisplatin‐Induced Hepatotoxicity in Rats: Targeting HMGB1/TLR4/NF‐κB and NLRP3/Caspase‐1 Signaling Pathways

open access: yesJournal of Biochemical and Molecular Toxicology, Volume 40, Issue 8, August 2026.
Graphical representation of the probable mechanisms underlying the effect of RUPA on CISP‐evoked hepatotoxicity in rats. ABSTRACT Despite cisplatin (CISP) is broadly employed in cancer therapy, its adverse effects, involving hepatotoxicity, restrict its clinical usage.
Shaimaa Mohamed Abdelrahman   +2 more
wiley   +1 more source

Disease Control, Activity and Quality of Life in Chronic Spontaneous Urticaria: A Cross-Sectional Study from Kazakhstan. [PDF]

open access: yesDiagnostics (Basel)
Batyrbayeva A   +8 more
europepmc   +1 more source

Patient Journey, Treatment Patterns, and Disease Burden of Patients With Idiopathic Hypereosinophilic Syndrome

open access: yeseJHaem, Volume 7, Issue 4, August 2026.
ABSTRACT Introduction Idiopathic hypereosinophilic syndrome (I‐HES) is a rare disorder characterized by persistent eosinophilia without an identifiable underlying cause, leading to organ damage and dysfunction. The objectives of this study were to describe the real‐world demographics, patient journey, treatment patterns, and disease burden of patients ...
Juliana Schwaab   +9 more
wiley   +1 more source

Identification of Clinical Factors Associated With the Immunogenicity of Homologous ChAdOx1‐nCoV‐19 Vaccine in Hemodialysis Patients

open access: yesThe Kaohsiung Journal of Medical Sciences, Volume 42, Issue 8, August 2026.
ABSTRACT Hemodialysis (HD) patients are at higher risk of severe COVID‐19 and may exhibit suboptimal vaccine responses. This study evaluates the factors influencing vaccine‐induced immunity in HD patients following the second dose of the Vaxzevria. A total of 276 HD patients and 126 controls were included. Antibody responses were assessed using binding
Chia‐Wei Chang   +9 more
wiley   +1 more source

Bee Bread Protects Small Intestinal Mucosa and Modulates Local Redox Responses in Streptozotocin‐Induced Diabetic Rats

open access: yesMolecular Nutrition &Food Research, Volume 70, Issue 16, 27 August 2026.
In streptozotocin‐induced diabetic rats, bee bread supplementation attenuated diabetes‐associated intestinal mucosal alterations and modulated local redox responses. Treatment reduced blood glucose levels and influenced the immunoreactivity patterns of Mn‐SOD and CAT, supporting a protective role of bee bread in maintaining small intestinal mucosal ...
Ebru Karadag Sari   +4 more
wiley   +1 more source

Reported Characteristics of Anaphylaxis Associated With Glatiramer Acetate: A Pharmacovigilance Analysis of the FDA and Canadian Databases

open access: yesPharmacology Research &Perspectives, Volume 14, Issue 4, August 2026.
ABSTRACT The FDA has mandated a Boxed Warning for glatiramer acetate (GA) due to the risk of serious anaphylactic reaction. This study aimed to characterize the reported features of GA‐associated anaphylaxis. Data mining was performed using the Reporting Odds Ratio (ROR) in the FDA Adverse Event Reporting System (FAERS) database (Q1 2004–Q1 2025) and ...
Tailei Nie   +4 more
wiley   +1 more source

Chronic spontaneous urticaria treatments and purinergic signaling: a therapeutic possibility. [PDF]

open access: yesJ Mol Med (Berl)
Fontana M   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy